Disfluent speech in patients with partial epilepsy: Beneficial effect of levetiracetam

Epilepsy and Behavior

Volumn 9, Issue 3, 2006, Pages 521-523

  Sechi, GianPietro ^a   Cocco, Giovanni A ^a   D'Onofrio, Marina ^a   Deriu, Maria G ^a   Rosati, Giulio ^a  

^a Neurological Clinic   (Italy)

Author keywords

Disfluent speech; Levetiracetam; Stuttering

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ABSENCE OF SIDE EFFECTS; ADD ON THERAPY; ADULT; ANTICONVULSANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MONITORING; ELECTROENCEPHALOGRAPHY; FEMALE; FLUENCY DISORDER; FOCAL EPILEPSY; HUMAN; MALE; OPEN STUDY; PROSPECTIVE STUDY; READING; STUTTERING;

ADULT; ANTICONVULSANTS; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRACETAM; PROSPECTIVE STUDIES; SPEECH DISORDERS;

EID: 33750283329     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2006.08.005     Document Type: Article

References (15)

1. Market K.E., Montague J.C., Buffalo J.C., and Drummond S.S. Acquired stuttering: descriptive data and treatment outcome. J Fluency Disord 15 (1990) 21-33
2. Brady J.P. Drug-induced stuttering: a review of the literature. J Clin Psychopharmacol 18 (1998) 50-54
3. Sechi G.P., Correddu P., Deiana G.A., Zucca G., and Rosati G. Expressive aphasia exacerbated by lamotrigine and gabapentin. Epilepsia 38 Suppl. 3 (1997) A73
4. Mula M., Trimble M.R., Thompson P., and Sander J. Topiramate and word-finding difficulties in patients with epilepsy. Neurology 60 (2003) 1104-1107
5. Canevini M.P., Chifferi R., and Piazzino A. Improvement of a patient with stuttering on levetiracetam. Neurology 59 (2002) 1288
6. Mulder L.J.M.M., and Spierings E.L.H. Stuttering relieved by divalproex sodium. Neurology 61 (2003) 714
7. Peterson C.L., Ferrara M.S., Mrazic M., Piland S., and Elliott R. Evaluation of neuropsychological domain scores and postural stability following cerebral concussion in sports. Clin J Sports Med 13 (2003) 230-237
8. Brown S., Ingham R.J., Ingham J.C., Laird A.R., and Fox P.T. Stuttered and fluent speech production: an ALE meta-analysis of functional neuroimaging studies. Hum Brain Mapp 25 (2005) 105-117
9. Foundas A.L., Bolltch A.M., Corey D.M., Hurely M., and Heilman K.M. Anomalous anatomy of speech-language areas in adults with persistent developmental stuttering. Neurology 57 (2001) 207-215
10. Gold M., Van Dam D., and Shuman I.R. An open-label trial of bromocriptine in nonfluent aphasia: a quantitative analysis of word storage and retrieval. Brain Lang 74 (2000) 141-156
11. Lynch B.A., Lambong N., Nocka K., et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101 (2004) 9861-9866
12. Piazzini A., Chiari R., Canevini M.P., Turner K., Paveri Fontana S., and Canger R. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy. Epilepsy Res 68 (2006) 181-188
13. Neyens L.G., Alpherts W.C., and Aldenkamp A.P. Cognitive effects on a new pyrrolidine derivate: levetiracetam in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 19 (1995) 411-419
14. Kessler J., Thiel A., Karbe H., and Heiss W.D. Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. Stroke 31 (2000) 2112-2116
15. Tallal P., Chase C., Russel G., and Schmitt R.L. Evaluation of the efficacy of piracetam in treating information processing, reading and writing disorders in dyslexic children. Int J Psychophysiol 4 (1986) 41-52